A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel

ABSTRACT

BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia. METHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500 mg) or a matching placebo capsule was administered twice daily for 12 weeks to the respective group of patients. The patients were followed up for 12 weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH). RESULTS: In 12 weeks, the major lipids such as total cholesterol (TC) (p = 0.0003), triglyceride (TG) (p = 0.0003), low density lipoprotein cholesterol (LDL-C) (p = 0.0064) and very low density lipoprotein cholesterol (VLDL-C) (p = 0.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p = 0.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p = 0.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p = 0.2942) or placebo groups (p = 0.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS > 100 mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study. CONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins. TRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered). More... »

PAGES

27

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y

DOI

http://dx.doi.org/10.1186/s12906-019-2430-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111593666

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30670010


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoprotein A-I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoproteins B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dyslipidemias", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypolipidemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phyllanthus emblica", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plant Extracts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triglycerides", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Aadhitya Adhikari Hospital, Contour Road, Gokulam, 570002, Mysore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Upadya", 
        "givenName": "Haridas", 
        "id": "sg:person.01300545725.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300545725.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "LifeCare Hospital, No.99, OM Complex, 20th Main, Gangothri Circle, BTM 1st Stage, 560029, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prabhu", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sri Venkateshwara Hospital, No.86, Hosur Main Road, Madiwala, 560068, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prasad", 
        "givenName": "Aravinda", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Syncretic Clinical Research Services, No. 4, 5th cross, 11th Main Road, Vasanthnagar, 560052, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Subramanian", 
        "givenName": "Deepa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amrita Institute of Medical Sciences and Research Centre", 
          "id": "https://www.grid.ac/institutes/grid.427788.6", 
          "name": [
            "Amrita School of Pharmacy, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, 682041, Kochi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gupta", 
        "givenName": "Swati", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411588.1", 
          "name": [
            "Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, 3410 Worth Street, Suite 610, 75246, Dallas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goel", 
        "givenName": "Ajay", 
        "id": "sg:person.0646110661.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646110661.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0378-8741(01)00361-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000269804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0009-9120(01)00263-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006385801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(01)07098-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007658337"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2010.10.047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007912357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2012.05.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009095252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0253-7613.93857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011677225"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)61965-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011777415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041433-200012000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016545005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041433-200012000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016545005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016775888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1194/jlr.m600233-jlr200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018155894"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(96)00677-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018432805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.numecd.2009.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018526495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/nyas.12540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019534589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-8741(95)01308-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019765319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0250-474x.27814", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026124607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01644.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027174221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.20.11.2408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027343904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0807646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029955328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2004.03.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030925161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12291-008-0083-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032016878", 
          "https://doi.org/10.1007/s12291-008-0083-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01649.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033739121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(92)90550-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035568674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pcd.2014.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036366641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lpm.2015.09.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036619188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0250-474x.44604", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037175074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01645.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038882970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehi003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039304662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.jef.2016.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044112364", 
          "https://doi.org/10.1016/j.jef.2016.02.002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(91)90742-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048418861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1373/clinchem.2004.033175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051062219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)17018-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052249325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.17.12.3542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063334594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074645527", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077052779", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077885458", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079538698", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079640587", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081924218", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082268876", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083234232", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/2333794x17694231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083873963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/2333794x17694231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083873963"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia.\nMETHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500\u2009mg) or a matching placebo capsule was administered twice daily for 12\u2009weeks to the respective group of patients. The patients were followed up for 12\u2009weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH).\nRESULTS: In 12\u2009weeks, the major lipids such as total cholesterol (TC) (p\u2009=\u20090.0003), triglyceride (TG) (p\u2009=\u20090.0003), low density lipoprotein cholesterol (LDL-C) (p\u2009=\u20090.0064) and very low density lipoprotein cholesterol (VLDL-C) (p\u2009=\u20090.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p\u2009=\u20090.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p\u2009=\u20090.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p\u2009=\u20090.2942) or placebo groups (p\u2009=\u20090.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS\u2009>\u2009100\u2009mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study.\nCONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins.\nTRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12906-019-2430-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028418", 
        "issn": [
          "1472-6882"
        ], 
        "name": "BMC Complementary and Alternative Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia", 
    "pagination": "27", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5e1af7b177f278dab2a5e510616ae090650be19d5a01f321dd7fbdabca8f516e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30670010"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088661"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12906-019-2430-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111593666"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12906-019-2430-y", 
      "https://app.dimensions.ai/details/publication/pub.1111593666"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60351_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12906-019-2430-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      21 PREDICATES      84 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12906-019-2430-y schema:about N0052a56854414bb699cce894850a06c1
2 N0a256148640c4fe588f6885c14a7a778
3 N17063f646d7c494fa0a8f1c8b737e080
4 N1fb525fb742f47ed8ea256ec41ecf61f
5 N236a02dd9b25457fb6d73d9d85596930
6 N450339feda0d4c359e09ef56bfbf47e0
7 N59d074ed209341549fba5e8176fa555a
8 N772f6add58dc431b8dbbb85be509c608
9 Nac6b0a778bc740d0a55ff3af322db6d1
10 Nd318eb748994401890ba57bd56679fa9
11 Nd4a6d2d4a2f34980bfccb879b15f0a85
12 Ne504c597b449449e8e1c4669ed54ed70
13 Ne50edd0fbb69445ea1695d04fbc2f34c
14 Nf00f53cc153a418e9aa9567ab9346580
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Ndcfe153217804448841128dadbb25ab6
18 schema:citation sg:pub.10.1007/s12291-008-0083-6
19 sg:pub.10.1016/j.jef.2016.02.002
20 https://app.dimensions.ai/details/publication/pub.1074645527
21 https://app.dimensions.ai/details/publication/pub.1077052779
22 https://app.dimensions.ai/details/publication/pub.1077885458
23 https://app.dimensions.ai/details/publication/pub.1079538698
24 https://app.dimensions.ai/details/publication/pub.1079640587
25 https://app.dimensions.ai/details/publication/pub.1081924218
26 https://app.dimensions.ai/details/publication/pub.1082268876
27 https://app.dimensions.ai/details/publication/pub.1083234232
28 https://doi.org/10.1016/0002-9149(91)90742-4
29 https://doi.org/10.1016/0002-9149(92)90550-i
30 https://doi.org/10.1016/0378-8741(95)01308-3
31 https://doi.org/10.1016/j.ahj.2004.03.021
32 https://doi.org/10.1016/j.jacc.2010.10.047
33 https://doi.org/10.1016/j.jacc.2012.05.019
34 https://doi.org/10.1016/j.lpm.2015.09.015
35 https://doi.org/10.1016/j.numecd.2009.11.002
36 https://doi.org/10.1016/j.pcd.2014.03.007
37 https://doi.org/10.1016/s0002-9149(96)00677-7
38 https://doi.org/10.1016/s0009-9120(01)00263-6
39 https://doi.org/10.1016/s0140-6736(01)07098-2
40 https://doi.org/10.1016/s0140-6736(04)17018-9
41 https://doi.org/10.1016/s0140-6736(09)61965-6
42 https://doi.org/10.1016/s0378-8741(01)00361-0
43 https://doi.org/10.1056/nejmoa0807646
44 https://doi.org/10.1093/eurheartj/ehi003
45 https://doi.org/10.1093/eurheartj/ehm360
46 https://doi.org/10.1097/00041433-200012000-00008
47 https://doi.org/10.1111/j.1365-2796.2006.01644.x
48 https://doi.org/10.1111/j.1365-2796.2006.01645.x
49 https://doi.org/10.1111/j.1365-2796.2006.01649.x
50 https://doi.org/10.1111/nyas.12540
51 https://doi.org/10.1161/01.atv.17.12.3542
52 https://doi.org/10.1161/01.atv.20.11.2408
53 https://doi.org/10.1177/2333794x17694231
54 https://doi.org/10.1194/jlr.m600233-jlr200
55 https://doi.org/10.1373/clinchem.2004.033175
56 https://doi.org/10.4103/0250-474x.27814
57 https://doi.org/10.4103/0250-474x.44604
58 https://doi.org/10.4103/0253-7613.93857
59 schema:datePublished 2019-12
60 schema:datePublishedReg 2019-12-01
61 schema:description BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia. METHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500 mg) or a matching placebo capsule was administered twice daily for 12 weeks to the respective group of patients. The patients were followed up for 12 weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH). RESULTS: In 12 weeks, the major lipids such as total cholesterol (TC) (p = 0.0003), triglyceride (TG) (p = 0.0003), low density lipoprotein cholesterol (LDL-C) (p = 0.0064) and very low density lipoprotein cholesterol (VLDL-C) (p = 0.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p = 0.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p = 0.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p = 0.2942) or placebo groups (p = 0.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS > 100 mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study. CONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins. TRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered).
62 schema:genre research_article
63 schema:inLanguage en
64 schema:isAccessibleForFree true
65 schema:isPartOf N1c9db9fa20f44f71beb27051c0dbf196
66 N1d959818f8664e2ebc29c4e6c5d4a943
67 sg:journal.1028418
68 schema:name A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
69 schema:pagination 27
70 schema:productId N0b30a02d530d497da580a901611c9685
71 N215f8bbd8313494087c1a9ee4a2edc32
72 N53879c7f205349a4a0790952b9198407
73 Nadc6db26b642477cb787b25d833eaaa2
74 Nb1d066dae26d4c0ba9999c73ae4fdfb9
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111593666
76 https://doi.org/10.1186/s12906-019-2430-y
77 schema:sdDatePublished 2019-04-11T11:02
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N37747982b1c449cf89da21c6704e8309
80 schema:url https://link.springer.com/10.1186%2Fs12906-019-2430-y
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N0052a56854414bb699cce894850a06c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Apolipoprotein A-I
86 rdf:type schema:DefinedTerm
87 N0a256148640c4fe588f6885c14a7a778 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Cholesterol
89 rdf:type schema:DefinedTerm
90 N0b30a02d530d497da580a901611c9685 schema:name nlm_unique_id
91 schema:value 101088661
92 rdf:type schema:PropertyValue
93 N17063f646d7c494fa0a8f1c8b737e080 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Hypolipidemic Agents
95 rdf:type schema:DefinedTerm
96 N1c9db9fa20f44f71beb27051c0dbf196 schema:volumeNumber 19
97 rdf:type schema:PublicationVolume
98 N1d959818f8664e2ebc29c4e6c5d4a943 schema:issueNumber 1
99 rdf:type schema:PublicationIssue
100 N1fb525fb742f47ed8ea256ec41ecf61f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Male
102 rdf:type schema:DefinedTerm
103 N215f8bbd8313494087c1a9ee4a2edc32 schema:name pubmed_id
104 schema:value 30670010
105 rdf:type schema:PropertyValue
106 N236a02dd9b25457fb6d73d9d85596930 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Triglycerides
108 rdf:type schema:DefinedTerm
109 N2dfc61acf1fd4fd2a9a4489963d60aed schema:name LifeCare Hospital, No.99, OM Complex, 20th Main, Gangothri Circle, BTM 1st Stage, 560029, Bangalore, India
110 rdf:type schema:Organization
111 N37747982b1c449cf89da21c6704e8309 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N450339feda0d4c359e09ef56bfbf47e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Plant Extracts
115 rdf:type schema:DefinedTerm
116 N53322dd3e3df4d42bd488a42d3a08075 schema:affiliation N2dfc61acf1fd4fd2a9a4489963d60aed
117 schema:familyName Prabhu
118 schema:givenName S.
119 rdf:type schema:Person
120 N53879c7f205349a4a0790952b9198407 schema:name readcube_id
121 schema:value 5e1af7b177f278dab2a5e510616ae090650be19d5a01f321dd7fbdabca8f516e
122 rdf:type schema:PropertyValue
123 N588d68493d214f7e8fe592a6fcc98cec schema:affiliation N87a717ff01b249b693fe4297344e6b94
124 schema:familyName Subramanian
125 schema:givenName Deepa
126 rdf:type schema:Person
127 N59d074ed209341549fba5e8176fa555a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Female
129 rdf:type schema:DefinedTerm
130 N5dd2c7b9a79b481284ac36eaed8d88b6 rdf:first sg:person.0646110661.20
131 rdf:rest rdf:nil
132 N6381faa2338f4c2390974011ece002db schema:name Sri Venkateshwara Hospital, No.86, Hosur Main Road, Madiwala, 560068, Bangalore, India
133 rdf:type schema:Organization
134 N6553d4920977478baa3616c7c7ad49db rdf:first N53322dd3e3df4d42bd488a42d3a08075
135 rdf:rest Na0260ede3923463f82f150252831419c
136 N772f6add58dc431b8dbbb85be509c608 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Middle Aged
138 rdf:type schema:DefinedTerm
139 N87a717ff01b249b693fe4297344e6b94 schema:name Syncretic Clinical Research Services, No. 4, 5th cross, 11th Main Road, Vasanthnagar, 560052, Bangalore, India
140 rdf:type schema:Organization
141 N8d4bd34fe29f46739e47f5a6bd815068 schema:name Aadhitya Adhikari Hospital, Contour Road, Gokulam, 570002, Mysore, India
142 rdf:type schema:Organization
143 N90c5e912ac47499b94eed600f58ecc4b rdf:first Nd9d262179251450683eba9aa16287a1c
144 rdf:rest N5dd2c7b9a79b481284ac36eaed8d88b6
145 N99b73b9891e542019c83c6dd76f47e32 schema:affiliation N6381faa2338f4c2390974011ece002db
146 schema:familyName Prasad
147 schema:givenName Aravinda
148 rdf:type schema:Person
149 Na0260ede3923463f82f150252831419c rdf:first N99b73b9891e542019c83c6dd76f47e32
150 rdf:rest Naf136694e6874015a11c4ff3d270fcb0
151 Nac6b0a778bc740d0a55ff3af322db6d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Phyllanthus emblica
153 rdf:type schema:DefinedTerm
154 Nadc6db26b642477cb787b25d833eaaa2 schema:name dimensions_id
155 schema:value pub.1111593666
156 rdf:type schema:PropertyValue
157 Naf136694e6874015a11c4ff3d270fcb0 rdf:first N588d68493d214f7e8fe592a6fcc98cec
158 rdf:rest N90c5e912ac47499b94eed600f58ecc4b
159 Nb1d066dae26d4c0ba9999c73ae4fdfb9 schema:name doi
160 schema:value 10.1186/s12906-019-2430-y
161 rdf:type schema:PropertyValue
162 Nd318eb748994401890ba57bd56679fa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Dyslipidemias
164 rdf:type schema:DefinedTerm
165 Nd4a6d2d4a2f34980bfccb879b15f0a85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Double-Blind Method
167 rdf:type schema:DefinedTerm
168 Nd9d262179251450683eba9aa16287a1c schema:affiliation https://www.grid.ac/institutes/grid.427788.6
169 schema:familyName Gupta
170 schema:givenName Swati
171 rdf:type schema:Person
172 Ndcfe153217804448841128dadbb25ab6 rdf:first sg:person.01300545725.35
173 rdf:rest N6553d4920977478baa3616c7c7ad49db
174 Ne504c597b449449e8e1c4669ed54ed70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Apolipoproteins B
176 rdf:type schema:DefinedTerm
177 Ne50edd0fbb69445ea1695d04fbc2f34c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 Nf00f53cc153a418e9aa9567ab9346580 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Adult
182 rdf:type schema:DefinedTerm
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1028418 schema:issn 1472-6882
190 schema:name BMC Complementary and Alternative Medicine
191 rdf:type schema:Periodical
192 sg:person.01300545725.35 schema:affiliation N8d4bd34fe29f46739e47f5a6bd815068
193 schema:familyName Upadya
194 schema:givenName Haridas
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300545725.35
196 rdf:type schema:Person
197 sg:person.0646110661.20 schema:affiliation https://www.grid.ac/institutes/grid.411588.1
198 schema:familyName Goel
199 schema:givenName Ajay
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646110661.20
201 rdf:type schema:Person
202 sg:pub.10.1007/s12291-008-0083-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032016878
203 https://doi.org/10.1007/s12291-008-0083-6
204 rdf:type schema:CreativeWork
205 sg:pub.10.1016/j.jef.2016.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044112364
206 https://doi.org/10.1016/j.jef.2016.02.002
207 rdf:type schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1074645527 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1077052779 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1077885458 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1079538698 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1079640587 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1081924218 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1082268876 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1083234232 schema:CreativeWork
216 https://doi.org/10.1016/0002-9149(91)90742-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048418861
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/0002-9149(92)90550-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1035568674
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/0378-8741(95)01308-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019765319
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/j.ahj.2004.03.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030925161
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/j.jacc.2010.10.047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007912357
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/j.jacc.2012.05.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009095252
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.lpm.2015.09.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036619188
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.numecd.2009.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018526495
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.pcd.2014.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036366641
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0002-9149(96)00677-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018432805
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0009-9120(01)00263-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006385801
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0140-6736(01)07098-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007658337
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0140-6736(04)17018-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052249325
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/s0140-6736(09)61965-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011777415
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/s0378-8741(01)00361-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000269804
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1056/nejmoa0807646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029955328
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1093/eurheartj/ehi003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039304662
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/eurheartj/ehm360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016775888
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1097/00041433-200012000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016545005
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1111/j.1365-2796.2006.01644.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027174221
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1111/j.1365-2796.2006.01645.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038882970
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/j.1365-2796.2006.01649.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033739121
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/nyas.12540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019534589
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1161/01.atv.17.12.3542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063334594
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1161/01.atv.20.11.2408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027343904
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1177/2333794x17694231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083873963
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1194/jlr.m600233-jlr200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018155894
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1373/clinchem.2004.033175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051062219
271 rdf:type schema:CreativeWork
272 https://doi.org/10.4103/0250-474x.27814 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026124607
273 rdf:type schema:CreativeWork
274 https://doi.org/10.4103/0250-474x.44604 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037175074
275 rdf:type schema:CreativeWork
276 https://doi.org/10.4103/0253-7613.93857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011677225
277 rdf:type schema:CreativeWork
278 https://www.grid.ac/institutes/grid.411588.1 schema:alternateName Baylor University Medical Center
279 schema:name Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, 3410 Worth Street, Suite 610, 75246, Dallas, TX, USA
280 rdf:type schema:Organization
281 https://www.grid.ac/institutes/grid.427788.6 schema:alternateName Amrita Institute of Medical Sciences and Research Centre
282 schema:name Amrita School of Pharmacy, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, 682041, Kochi, India
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...